Atlas Trials

Clinical Efficacy of Fosfomycin Trometamol Per os in the Treatment of Documented Male Urinary Tract Infections With ESBL-producing Enterobacteriaceae With ESBL Producing Enterobacteriaceae and Resistance Associated With Fluoroquinolones and Cotrimoxazole (FOSF'HOM)

Clinical trial NCT03868969 · UNKNOWN

Trial details

NCT number
NCT03868969
Sponsor
Centre Hospitalier Universitaire de Besancon
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Urinary Tract Infections
Start date
2019-04-01
Primary completion
2021-04-01
Enrollment
25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.